News
On Monday, July 14, the FDA announced that it has approved the use of the natural color additive gardenia (genipin) blue for dying a variety of foods and drinks. This is the fourt ...
The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...
Gardenia (genipin) blue is the fourth natural food color additive the FDA has approved this year, but how is it made?
Months after the FDA approved three natural food additives, it's added another to the list. Experts share what parent should ...
The White House asked companies to remove Red No. 3, an artificial color in candy and cereal, sooner than the 2027 deadline ...
The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
Imagion shares are on a tear after the US FDA said it had no objections to the proposed conduct of a phase II breast cancer imaging trial.
20h
Zacks Investment Research on MSNBayer Gets FDA Nod for Label Expansion of Kerendia in Heart FailureBayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.
Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results